杨欣妤
主管药师
专业职称：主管药师
教学职称：讲师
学位：硕士学位
联系方式：010-63926340
个人简介：
药剂科主管药师，讲师。作为北京市优秀人才“青年拔尖团队”、北京市医院管理中心“登峰”计划骨干及院高层次人才骨干后备，主要从事药理学研究工作。代表性文章发表在AJHG IF:9.8 、Phytomedicine IF:7.9、ACS Omega、DIABET METAB SYND OB等国际期刊上，成果被《The Lancet》杂志在The Lancet and CAMS Health 会议上以Poster形式报道。主持国家自然基金1项、北京市自然基金1项及院级课题1项，参与科技部重大专项1项、国家自然基金重点项目1项及面上项目4项。申请专利3项，已授权1项。
陕西中医药大学二导师
中华中医药学会会员
中国抗癌协会会员
Frontiers in Nutrition审稿人
2019年 优秀员工
2020年 优秀员工
2021年 优秀员工
2021.1-2023.12 小檗碱改善胰岛 β 细胞损伤的 Hormesis 效应及分子机制研究 8200140012
2018.1-2020.12 基于 SGLT1 葡萄糖感应调节通路的黄连改善糖耐量受损的新机制研究 7194280
2017.1-2018.12 EPB41基因表达在食管癌中的作用及其与化疗药物敏感性关系 2016-q17
鄢丹, 张蕾, 冯兴中, 杨欣妤, 乐世俊, 王晓芳, 杨智睿, 孟欣彤, 刘娟. 一种治疗糖尿病前期的药物组合物. 中国专利, 已授权，ZL201810062698.8
1.Man-zhong Li, Lei Zhang, Zheng-yuan Shi, De-chun Jiang(*), Xin-yu Yang(*).Magnetic resonance imaging detects cerebral gray and white matter injury correlated with cognitive impairments in diabetic db/db mice[J]. Behavioural Brain Research, 2023, 451:114510
2.Yang Xinyu (#), Wang Wenxiao (#), Huang Yuxi (#), Yue Shijun (*), Zhang Baiyang , Gao Huan, Zhang Lei , Yan Dan,Tang Yuping(*).Network Pharmacology-Based Dissection of the Active Ingredients and Protective Mechanism of the Salvia Miltiorrhiza and Panax Notoginseng Herb Pair against Insulin Resistance[J]. ACS Omega,2021, 6(27):17276-17288.
3.Huang Mingyue(#), Yang Xinyu(#), Wang Zhenzhen, Long Jianglan, Wang Aiting, Zhang Yi,Yan Dan. Lipophagy: A New Perspective of Natural Products in Type 2 Diabetes Mellitus Treatment[J]. Diabetes, Metabolic Syndrome and Obesity: Targets and Therap,2021, 14:2985-2999.
4.Tao Huijuan(#), Yang Xinyu(#), Wang Wenxiao, Yue Shijun(*),Pu Zongjin, Huang Yuxi, Shi Xuqin, Chen Jiaqian, Zhou Guisheng, Chen Yanyan, Zhao Ming,Tang Yuping(*), Duan Jin-ao. Regulation of serum lipidomics and amino acid profiles of rats with acute myocardial ischemia by Salvia miltiorrhiza and Panax notoginseng herb pair. Phytomedicine,2020, 67:153162.
5.Yang Xinyu(#), Yu Dianke(#), Ren Yanli, Wei Jinyu, Pan Wenting, Zhou Changchun, Zhou Liqing, Liu Yu, Yang Ming. Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk. AJHG, 2016,99(2):275-86.
6.Yang Xinyu(#), Gao Feng(#), Ma Fei(#), Ren Yanli, Chen Hongwei, Liang Xue, Han Sichong, Xiong Xiangyu, Pan Wenting, Zhou Changchun, Zhou Liqing, Yang Ming. Association of the functional BCL-2 rs2279115 genetic variant and small cell lung cancer. Tumor Bio, 2016.
7.Yang Xinyu(#), Yu Dianke(#), Ren Yanli, Wei Jinyu, Pan Wenting, Zhou Changchun, Zhou Liqing, Yang Ming. EPB41, a novel hepatoma susceptibility gene dysregulated by c-Myc: an integrative functional genomics study. Lancet-Chinese-Academy-of-Medical-Sciences (CAMS) Health Summit, Beijing,2016.
8.杨欣妤，黄明月，时正媛，鄢丹.基于肠道L细胞葡萄糖转运体表达的小檗碱降糖机制研究[J].中华中医药杂志 2020. 36(4):1926-1930.
